advertisement
Mizoue S 18
Showing records 1 to 18 |
Display all abstracts from Mizoue S73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension GlaucomaMizoue S
Advances in Therapy 2017; 34: 1438-1448
72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucomaAoki S
British Journal of Ophthalmology 2017; 101: 1658-1665
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension GlaucomaNitta K
Advances in Therapy 2017; 34: 1438-1448
72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucomaMurata H; Fujino Y
British Journal of Ophthalmology 2017; 101: 1658-1665
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension GlaucomaShirakashi M
Advances in Therapy 2017; 34: 1438-1448
72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucomaMatsuura M
British Journal of Ophthalmology 2017; 101: 1658-1665
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension GlaucomaNitta A
Advances in Therapy 2017; 34: 1438-1448
72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucomaMiki A
British Journal of Ophthalmology 2017; 101: 1658-1665
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension GlaucomaYamabayashi S; Kimura T
Advances in Therapy 2017; 34: 1438-1448
72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucomaTanito M
British Journal of Ophthalmology 2017; 101: 1658-1665
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension GlaucomaUeda T
Advances in Therapy 2017; 34: 1438-1448
72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucomaMizoue S
British Journal of Ophthalmology 2017; 101: 1658-1665
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension GlaucomaTakeda R
Advances in Therapy 2017; 34: 1438-1448
72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucomaMori K; Suzuki K
British Journal of Ophthalmology 2017; 101: 1658-1665
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension GlaucomaMatsumoto S
Advances in Therapy 2017; 34: 1438-1448
72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucomaYamashita T
British Journal of Ophthalmology 2017; 101: 1658-1665
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension GlaucomaYoshikawa K
Advances in Therapy 2017; 34: 1438-1448
72961 Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucomaKashiwagi K; Hirasawa K; Shoji N; Asaoka R
British Journal of Ophthalmology 2017; 101: 1658-1665